Die Paper zu diesem Podcast:
- Zur Dauer der Immunantwort:
Eric Laing et al, medRxiv, 2021 "SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity"
- Antikörper-Antwort auf Infektion (Kölner Studie):
Kanika Vanshylla et al, Cell Host & Microbe, 2021, "Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans"
- Immun-T-Zell-Antwort nach Impfung:
Kathleen Gallagher et al, bioRxiv, 2021, "SARS-CoV-2 T-cell immunity to variants of concern following vaccination"
- Immunantwort bei Krebskranken:
Leticia Monin et al, Lancet Oncology, 2021 "Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study"
Fler avsnitt av F.A.Z. Wissen
Visa alla avsnitt av F.A.Z. WissenF.A.Z. Wissen med Frankfurter Allgemeine Zeitung finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
